BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22439013)

  • 1. Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
    Rottlaender D; Motloch LJ; Schmidt D; Reda S; Larbig R; Wolny M; Dumitrescu D; Rosenkranz S; Erdmann E; Hoppe UC
    PLoS One; 2012; 7(3):e33902. PubMed ID: 22439013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters.
    Schönbauer R; Duca F; Kammerlander AA; Aschauer S; Binder C; Zotter-Tufaro C; Koschutnik M; Fiedler L; Roithinger FX; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J
    Eur J Clin Invest; 2020 Feb; 50(2):e13184. PubMed ID: 31732964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure.
    Dickinson MG; Lam CS; Rienstra M; Vonck TE; Hummel YM; Voors AA; Hoendermis ES
    Eur J Heart Fail; 2017 Nov; 19(11):1483-1490. PubMed ID: 28948687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure.
    Schnorbach J; Fröhlich H; Täger T; Corletto A; Katus HA; Frankenstein L
    ESC Heart Fail; 2019 Aug; 6(4):640-648. PubMed ID: 31259484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension.
    Fingrova Z; Havranek S; Ambroz D; Jansa P; Linhart A
    BMC Cardiovasc Disord; 2019 Jun; 19(1):157. PubMed ID: 31253083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels.
    Al-Khalili F; Kemp-Gudmundsdottir K; Svennberg E; Fredriksson T; Frykman V; Friberg L; Rosenqvist M; Engdahl J
    Open Heart; 2020; 7(1):e001200. PubMed ID: 32153793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction.
    Prapan N; Ratanasit N; Karaketklang K
    BMC Cardiovasc Disord; 2020 Oct; 20(1):433. PubMed ID: 33023481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation.
    Bai M; Yang J; Li Y
    Clin Cardiol; 2009 Dec; 32(12):E1-5. PubMed ID: 20014208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.
    Li Y; Wang Y; Meng X; Zhu W; Lu X
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1737-1748. PubMed ID: 28553693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation.
    Kabukçu M; Arslantas E; Ates I; Demircioglu F; Ersel F
    Angiology; 2005; 56(2):159-63. PubMed ID: 15793605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
    Corell P; Gustafsson F; Kistorp C; Madsen LH; Schou M; Hildebrandt P
    Int J Cardiol; 2007 May; 117(3):395-402. PubMed ID: 16919342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.